Login / Signup

An update on VEXAS syndrome.

Adam Al-HakimSinisa Savic
Published in: Expert review of clinical immunology (2022)
negative cases are reported. Consensus diagnostic criteria might be required to define VEXAS and its related disorders. Investigation of sporadic, VEXAS-like cases will require the application of deep sequencing using DNA obtained from various cellular or tissue locations. Prospective studies are needed to define the optimal supportive and treatment options for patients with varying disease severity and prognosis. VEXAS-specific hematopoietic stem cell transplant selection criteria also require development.
Keyphrases
  • hematopoietic stem cell
  • circulating tumor
  • late onset
  • single cell
  • cell free
  • single molecule
  • case report
  • amyotrophic lateral sclerosis
  • case control
  • early onset